Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

27.22 +0.73 (+2.76%)
Official Closing Price Updated: 7:00 PM EST, Feb 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Pfizer

< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
39 40 Next >
News headline image
PFIZER REPORTS STRONG THIRD-QUARTER 2022 RESULTS AND RAISES 2022 OUTLOOK
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Announces Positive Top-Line Data of Phase 3 Global Maternal Immunization Trial for its Bivalent Respiratory Syncytial Virus (RSV) Vaccine Candidate
From Pfizer Inc.
Via Business Wire
News headline image
Why Investors Are Suddenly Excited About Vaxcyte
Vaxcyte, Inc. is a small cap biotech company that catapulted back to mid-cap land with a stunning 110% surge — and may not be done yet. 
Via MarketBeat
News headline image
Author A. D. Stowers' New Book 'Michaela's Miracle' is a Stirring True Story of Loss, Heartache and Joy Centered Around a Young Woman Who Comes to Understand Love
Recent release 'Michaela's Miracle' from Covenant Books author A. D. Stowers is an impactful tale based on true events that follow Michaela, who has only ever known rejection and abandonment her entire... 
Via Newswire.com
News headline image
Pfizer Stock Falls After a Tax Investigation Is Launched Against the Company in Italy
Pfizer Stock (NYSE:PFE) According to a story published on Thursday by Reuters, which cited two individuals with knowledge of the situation, the tax authorities in Italy are probing the earnings... 
Via PressReach
News headline image
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Pfizer Inc. (PFE) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Pfizer Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Pfizer Inc. (PFE) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Eli Lilly Dividend: Does Eli Lilly Pay Dividends?
Yes, Eli Lilly and Company (NYSE: LLY) pays dividends but there is more to investing in this stock than a simple “yes” answer. The Eli Lilly dividend is safe enough but it may not be right for all... 
Via MarketBeat
News headline image
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Pfizer Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
The Law Offices of Frank R. Cruz Announces Investigation of Pfizer Inc. (PFE) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Erasca Announces Clinical Trial Collaboration and Supply Agreement with Pfizer to Evaluate ERAS-007 and Palbociclib Combination
From Erasca, Inc.
Via GlobeNewswire
News headline image
Pfizer Presents Scientific Advancements in Infectious Disease Prevention and Treatments at IDWeek 2022
From Pfizer Inc.
Via Business Wire
News headline image
MarketBeat: Week in Review 10/10-10/14
A volatile week is ending with the market moving lower. Here are some of the stories the MarketBeat analysts were covering this week. 
Via MarketBeat
Pharma Trend Honors the Best Pharmaceutical Companies and the Most Innovative Products 2022
Via Magic PR
News headline image
Global Antivenom Market Size to Surpass US$ 1057.6 Million by 2027
Global Antivenom Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application 
Via SBWire
News headline image
Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in Children 5 Through 11 Years of Age
From Pfizer Inc.
Via Business Wire
News headline image
Is Pfizer Stock Still Worth Buying After the Pandemic?
Pharmaceutical giant Pfizer (NYSE: PFE) is literally synonymous with COVID-19 vaccines, and as a result, Pfizer stock continues to beat expectations. 
Via MarketBeat
News headline image
CAPEX.com Launches Share Dealing and ETF Trading Product - CAPEX Invest
Bucharest, Romania--(Newsfile Corp. - October 5, 2022) - After previously announcing a zero-commission pre-launch campaign for share dealing, CAPEX.com unveils... 
Via Newsfile
Topics ETFs
News headline image
Pfizer Completes Acquisition of Global Blood Therapeutics
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Announces Positive Topline Results from Phase 3 TALAPRO-2 Trial
From Pfizer Inc.
Via Business Wire
CFund Capital to Present at Blockchain Expo North America October 5-6
Markham, ON () October 3, 2022 -- CFund is a professional platform integrating investor education, liquidity provision and crypto asset management. 
Via Prodigy
Topics Economy
News headline image
Pfizer Completes Acquisition of Biohaven Pharmaceuticals
From Pfizer Inc.
Via Business Wire
The Road to Health never ends
Via eTrendy Stock
News headline image
Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster in Children 5 Through 11 Years of Age
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Declares Fourth-Quarter 2022 Dividend
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer to Supply Global Fund Up to 6 Million PAXLOVID™ Treatment Courses for Low-and-Middle-Income Countries
From Pfizer Inc.
Via Business Wire
News headline image
Novavax Remains a Risk-On Stock in a Risk-Off Market
NVAX is a risk-on stock at a time investors are turning to risk-off assets. This article looks to see if Novavax still presents an opportunity for investors 
Via MarketBeat
Topics Earnings
News headline image
Pfizer Invites Public to View and Listen to Webcast of November 1 Conference Call with Analysts
From Pfizer Inc.
Via Business Wire
< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
39 40 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.